Clinical Trials Logo

Clinical Trial Summary

Stress hyperglycaemia is a well-known risk factor of postoperative morbidity and mortality in cardiac surgery. Recently, several authors have reported that increased blood glucose (BG) variability could worsen the prognosis in this population.The transcatheter aortic valve implantation (TAVI) is a low invasive procedure proposed as an alternative technique to aortic valve replacement surgery in high-risk patients.

The aim of this study is to describe the incidence of stress hyperglycaemia and assess whether BG variability could impact the outcome of patients undergoing TAVI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02726958
Study type Observational
Source Centre Hospitalier Universitaire de Besancon
Contact
Status Completed
Phase N/A
Start date March 2014
Completion date September 2014

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02946411 - Correlation of Hospital Stay Length With the Glucose Levels After Cardiac Surgery
Completed NCT04408768 - Stress Hyperglycemia and Acute Ischemic Stroke
Terminated NCT03743025 - Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients Phase 4
Not yet recruiting NCT05314725 - Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial Phase 2
Completed NCT01969149 - Exenatide for Stress Hyperglycemia Phase 2/Phase 3
Terminated NCT02068989 - Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus N/A
Completed NCT02847104 - Medical ICU Paper-based Dynamic Insulin Protocol N/A
Not yet recruiting NCT01776476 - A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma Phase 2
Recruiting NCT02180555 - Diabetes Mellitus After Intensive Care Admission N/A
Not yet recruiting NCT04591561 - Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital